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Glycaemic control, in particular at postprandial period, has a key role in prevention of different diseases, including diabetes and
cardiovascular events. Previous studies suggest that postprandial high blood glucose levels (BGL) can lead to an oxidative stress
status, which is associated with metabolic alterations. Cinnamon powder has demonstrated a beneficial effect on postprandial
glucose homeostasis in animals and human models. The purpose of this study is to investigate the effect of cinnamon tea (C.
burmannii) on postprandial capillary blood glucose level on nondiabetic adults. Participants were given oral glucose tolerance
test either with or without cinnamon tea in a randomized clinical trial. The data revealed that cinnamon tea administration
slightly decreased postprandial BGL. Cinnamon tea ingestion also results in a significantly lower postprandial maximum glucose
concentration and variation of maximum glucose concentration (p < 0.05). Chemical analysis showed that cinnamon tea has a high
antioxidant capacity, which may be due to its polyphenol content.The present study provides evidence that cinnamon tea, obtained
from C. burmannii, could be beneficial for controlling glucose metabolism in nondiabetic adults during postprandial period.
1. Introduction
Postprandial glucose level (PBG) has been reported to be an
important factor in glycaemic control [1, 2]. The importance
of postprandial glycaemia regulation is in accordance with
epidemiological studies, which have demonstrated that post-
prandial hyperglycaemia is a predictor of diabetes and car-
diovascular events [3, 4].The postprandial state can stimulate
the reactive oxygen species (ROS) production leading to an
oxidative stress status. This status involves molecular mech-
anism for development of different complications associated
with hyperglycaemia [5–7]. Moreover, postprandial oxidative
stress can be accompanied by postprandial inflammation and
endothelial dysfunction as reported by Ceriello et al. [8].
Postprandial glucose concentration refers to plasma glu-
cose concentration after eating, which can be evaluated using
a reference test standardized, 75 g oral glucose tolerance
test (OGTT) [9]. During OGTT, plasma glucose level is
obtained by secretion/action of insulin [10]. However, many
other factors can also influence glucosemetabolism including
timing, quantity, and meal composition [11–13].
Many traditional plants and spices possess medicinal
properties, such as control blood glucose levels. Cinnamon
is one of these spices that has been demonstrated to be
effective in improving glycaemia [14, 15] both in healthy
and diabetic subjects. In healthy subjects, a study revealed
that 5 g of cinnamon powder lowered PBG after OGTT
[16] and another showed that 6 g added to a rice pudding
improved PBG area under the curve (AUC) [17]. In type
2 diabetic subjects, cinnamon revealed that it can exert
a hypoglycaemic effect, decreasing PBG and fasting blood
glucose level (FBG) [18]. These beneficial effects seem to be
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related to its water-soluble polyphenols. An in vitro study
showed that polyphenols possess an insulin-like action [19].
In addition, these cinnamon bioactive compounds revealed
high antioxidant properties in human and animal models on
oxidative stress through inhibiting lipid peroxidation [20, 21].
The aim of the present study is to investigate the effect of
a cinnamon tea (6 g C. burmannii/100mL) on postprandial
capillary blood glucose level on nondiabetic adults.
2. Material and Methods
2.1. Subjects. Following ethical committee approval 30 non-
diabetic adults with ages between 20 and 53 years were
selected from the local community to participate in this
study. A written informed consent was obtained from each
volunteer after explaining the aim and experiment risk
procedures. Inclusion criteria included subjects aged 18 or
more, both genders with nondiabetic condition (fasting
blood glucose level < 100mg/dL [22]). Exclusion criteria
comprised individuals who use medication for glycaemia
control and have gastrointestinal symptoms or diseases. The
study also excluded subjects who have altered medication,
pregnancy, lactation, and allergy to cinnamon.
2.2. Study Design. Thirty nondiabetic adults were selected
and randomly allocated in 2 groups (𝑛 = 15): control group,
oral glucose tolerance test (OGTTcontrol) alone, and interven-
tion group, OGTT followed by cinnamon tea administration
(OGTTcinnamon). The participants were asked not to ingest
any cinnamon at the day before the intervention.
2.3. Subject Groups Characterization. At baseline (before
interventions), general characteristic data, such as anthropo-
metric data, medical condition, and pharmacological ther-
apy, were collected using a questionnaire development by
investigator. Participants were also questioned about usual
cinnamon intake. A 24-hour dietary recall was taken pre-
ceding each intervention to compare food intake at the day
before the intervention between groups. The Food Processor
SQL (version 10.5.0) programme was used to analyse the
nutritional composition of the food.
2.4. Oral Glucose Tolerance Test (OGTT). The glucose
(dextrose) was weighed (75 g) using an analytical balance
and dissolved in 200mL of water, according to American
Dietetic Association [22]. Following overnight fasting (12 h)
blood glucose level was measured using a capillary drop
blood, before intervention (𝑡
0
). In control group, subjects
ingested glucose solution (200mL) alone (OGTTcontrol). In
intervention group subjects ingested 100mL cinnamon tea
(OGTTcinnamon) immediately after glucose solution (200mL)
intake. Blood samples were collected, for each participant, at
30 (𝑡
30
), 60 (𝑡
60
), 90 (𝑡
90
), and 120 (𝑡
120
)minutes in control and
intervention groups. Sterilized lancet, glucose meter equip-
ment, and strips for glucose meter (FreeStyle Abbott Diabetes
Care) were used for blood glucose level measurement.
2.5. Chemicals and Equipment for Antioxidant Capacity Stud-
ies. Ferric chloride (III) hexahydrate (FeCl
3
⋅6H
2
O), Folin-
Ciocalteu (2,2-azinobis(3-ethylbenzothiazoline-6-sulfonic
acid)), Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-car-
boxylic acid), TPTZ 2,4,6-tri(2-pyridyl)-s-triazine, methanol
(CH
3
OH), nicotinamide adenine dinucleotide (NADH),
nitroblue tetrazolium (NBT) 2-amino-2-hydroxymethyl-
propane-1,3-diol (tris), and phenazine methosulfate (PMS)
were purchased from Sigma-Aldrich, gallic acid-1-hydrate
(C
6
H
2
(OH)
3
COOH⋅H
2
O) was purchased from Acros
Organics, and sodium carbonate (Na
2
CO
3
) was purchased
from ICS Science group. All reagents were pro analysis grade.
All the absorbance measurements were performed in a
Perkin-Elmer Lambda 25. The regents were weighed in an
analytical balance (Sartorius, ±0.0001 g) and all the solutions
were done with distilled water.
2.6. Cinnamon Tea Preparation. The Cinnamomum burman-
nii bark was purchased from Sucrame Company (Portugal)
with Indonesia origin. Sticks of cinnamon (60 g) were soaked
into 1000mL of water. After 24 h at room temperature,
cinnamon solution was heated for 30min at 100∘C and then
filtered at room temperature. This method was adapted by
Shen and coauthors [23]. After the cinnamon tea preparation
a 100mL individual dose was distributed to each participant.
For chemical analysis, a hydromethanolic extract (50 : 50)was
performed with cinnamon tea previously obtained.
2.7. Total Phenolic Content Determination. The total phenolic
concentration in the extract was determined according to
Folin-Ciocalteu method [24] employing gallic acid as stan-
dard. The results were expressed as mg for gallic acid equiv-
alent (GAE)/g of extract. A volume of 375 𝜇L of cinnamon
extract and 4mL of sodium carbonate were added to 5mL
of Folin-Ciocalteu reagent. After 15min the absorbance was
measured at 765 nm.This test was performed for 8 replicates.
2.8. Antioxidant Assay Using Ferric Reducing Antioxidant
Power (FRAP) Method. The method for determination of
ferric reducing effect was based on the reduction, at low
pH, employing a colourless ferric complex (Fe3+) to a
blue-coloured ferrous complex (Fe2+) by electron-donating
antioxidants action in 2,4,6-tri(2-pyridyl)-s-triazine (TPTZ)
presence [25]. A fresh solutionwas prepared bymixing 25mL
of acetate buffer (300mM, pH = 3.6) into 2.5mL of TPTZ
solution (10mM) to HCl (40mM) and 2.5mL of FeCl
3
⋅6H
2
O
solution (20mM). The solution was heated at 37∘C. Samples
(150 𝜇L) were introduced in tubes with 2850𝜇L of the FRAP
solution and were maintained in the dark condition for
30min. The absorbance was measured at 593 nm. Trolox (6-
hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) was
used as standard and the results were expressed in 𝜇mol
Trolox/L. This test was performed for 6 replicates.
2.9. Superoxide Anion Radicals Scavenging Activity (O2∙−).
Superoxide anion was generated by reacting phenazine
methosulfate (PMS), nicotinamide adenine dinucleotide
hydride (NADH), and oxygen causing reduced NBT in
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Formazan [26, 27]. A volume of 0.5mL of sample was added
to 2mL of a solution containing NADH (189 𝜇M) and NBT
(120𝜇M) with Tris-HCl (40mM, pH = 8). The reaction
started after the addition of 0.5mL of PMS (60mM). Control
sample was measured using only distilled water. After 5min
of incubation, control absorbance was measured at 560 nm
at room temperature. Absorbance was measured for different
concentrations of cinnamon samples in order to represent
a curve of % of inhibition versus phenolic concentration.
The percentage of superoxide anion inhibition was calculated
using the following equation:
% 𝐼 = Abs control − Abs corrected sample
Abs control
× 100. (1)
2.10. Statistical Analysis. Statistical analysis was performed
using Excel and SPSS Statistics (Statistical Package for Social
Sciences) version 20.0 software for Windows. Data are pre-
sented as mean ± SD. Repeated Measures ANOVA of mixed
type was used to assess the difference between the 2 groups
for postprandial BGL at different times.
Independent samples 𝑡-test was used to assess the dif-
ference between the 2 groups for total caloric value, carbo-
hydrates, protein and lipid, 𝐶max, Δ𝐶max, and AUCIncremental
values.
All statistical tests were performed at the 5% level of
significance.
3. Results
3.1. General Characteristics of Participants. The general char-
acteristics of the study participants are shown in Table 1,
reporting age, anthropometrics parameters, medical condi-
tions, and pharmacologic therapy. The BMI data for both
genders revealed that most of participants have regular
weight [28]. Regarding body fat mass (FM) the results show
that the sample subjects are also in normal range in both
genders [28], but female had significantly more fat mass than
male. In addition, female subject had significantly (𝑝 < 0.05)
less muscular mass than male.
In what concerns the ingestion of total energy intake and
macronutrient composition regarding carbohydrates, protein
and lipid at the day before the intervention, the 2 groups
can be considered homogeneous since they did not reveal
significant differences (𝑝 > 0.05) (Table 2).
3.2. Postprandial Blood Glucose Level. Blood glucose levels
(BGL) were measured for the 2 groups (OGTT
(control) and
OGTT
(cinnamon)) (Table 3). Statistical analysis revealed that
there is no interaction between the independent and repeated
measures factors (𝑝 = 0.209), which means that it is
not possible to infer about differences in BGL in different
moments.
However, the data showed that the administration of
cinnamon tea after OGTT slightly decreased BGL mean
values compared toOGTT in the absence of cinnamon intake
(Figure 1).
The administration of cinnamon tea after OGTT resulted
in a lower but not significantly postprandial blood glucose
Table 1: Characteristics of the study participants (𝑛 = 30). Data
represented mean (±SEM).
Control group Cinnamon group
Mean (±SEM) Mean (±SEM)
Age (years)
Males 35.3 (±6.7) 30.2 (±3.7)
Females 38.3 (±3.5) 34.3 (±3.1)
BMI (Kg/m2)
Males 23.6 (±1.2) 24.9 (±0.7)
Females 24.8 (±1.1) 24.1 (±0.7)
FM (%)
Males 15.1 (±2.1) 17.2 (±0.8)
Females 27.6 (±1.7) 28.0 (±1.7)
MM (%)
Males 52.7 (±2.1) 67.1 (±1.5)
Female 42.1 (±1.7) 41.8 (±1.3)
BMI: body mass index; FM: fat mass; MM: muscular mass.
Table 2: Dietary analysis of total energy intake (TEI), carbohydrates
(CD), protein (P), and lipid (L) intake at the day before OGTT(control)
and at the day before OGTT(cinnamon) by participants. Data are mean
± SEM; 𝑛 = 15, each group.
Dietary
Parameters
Day before
OGTT(control)
Mean (±SEM)
Day before
OGTT(cinnamon)
Mean (±SEM)
𝑝
TEI (Kcal) 1708.01 (±97.04) 1736.51 (±113.74) 0.850
CD (g) 216.04 (±19.32) 225.40 (±15.33) 0.707
P (g) 75.66 (±6.15) 77.67 (±6.49) 0.823
L (g) 58.54 (±4.6) 58.47 (±6.61) 0.993
Independent sample 𝑡-test was used for statistical analysis.
Table 3: Mean blood glucose levels (mmol/L) obtained after oral
glucose tolerance test (OGTT(control)) and after oral glucose tolerance
test with cinnamon tea (OGTT(cinnamon)) at different moments:
before OGTT (𝑡
0
) and after 30 (𝑡
30
), 60 (𝑡
60
), 90 (𝑡
90
), and 120 (𝑡
120
)
minutes. Data are mean ± SEM; 𝑛 = 15, each group.
Time
OGTT(control)
Mean (±SEM)
mmol/L
OGTT(cinnamon)
Mean (±SEM)
mmol/L
𝑡
0 4.97 (±0.1) 4.99 (±0.1)
𝑡
30 10.14 (±0.4) 8.87 (±0.4)
𝑡
60 8.75 (±0.5) 8.24 (±0.4)
𝑡
90 7.66 (±0.5) 7.29 (±0.3)
𝑡
120 6.40 (±0.2) 5.86 (±0.2)
incremental area under the curve (AUCi) compared with
OGTT
(control). However, the variation of maximum glucose
concentration and maximum glucose concentration mean
values were significantly lower (𝑝 < 0.05) in OGTT
(cinnamon)
compared with OGTT
(control) (Table 4).
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Table 4: Blood glucose level area under the curve (AUC),maximum
glucose concentration (𝐶max), and variation of maximum glucose
concentration (Δ𝐶max) in nondiabetic subjects at OGTT(control) and
OGTT(cinnamon). Data are mean ± SEM (𝑛 = 15).
OGTT(control) OGTT(cinnamon)
𝑝Mean (±SEM) Mean (±SEM)
(mmol/L) (mmol/L)
AUCi (0–120min) 403.73 (±48.5) 297.47 (±33.9) 0.084
𝐶max 10.63 (±0.6) 8.98 (±0.5) 0.040
∗
Δ𝐶max 5.71 (±0.6) 4.0 (±0.5) 0.029
∗
Independent samples 𝑡-test was assessed (∗differences for 𝑝 < 0.05).
Table 5: Total phenolic content, antioxidant capacity of cinnamon
tea. Values are mean ± SEM.
Chemical analysis Mean (±SEM)
Total phenols (mg/L gallic acid, 𝑛 = 8) 2286,3 (±48,0)
Antioxidant capacity: FRAP assay
(𝜇mol Trolox/L, 𝑛 = 6) 11853,4 (±322,8)
3.3. Total Phenol Content and Antioxidant Capacity. The data
in Table 5 showed the total phenolic content, antioxidant
capacity of cinnamon tea ingested by the participant. The
superoxide anion radical scavenging activity (O2
∙−) was
measured at different concentration of C. burmannii tea. The
results revealed that cinnamon tea has a strong inhibitory
capacity, in a dose dependent manner, reaching 96% at
1143mg/L gallic acid (half of the total phenols).
4. Discussion
Cinnamon capsule ingestion with either aqueous extract
or cinnamon powder appears to improve fasting blood
glucose level, independently of cinnamon species or extracts
[15, 29]. Doubly linked polyphenol type-A polymers were
identified, in the Ziegenfuss et al. study, as one of the possible
bioactive compounds responsible for this effect [30]. In this
study the administration of aqueous C. burmannii extract
capsule (Cinnulin PF), with 1% of doubly linked polyphenol
type-A polymers, improved fasting blood glucose levels, in
prediabetes subjects. Moreover, in type 2 diabetic subjects
or impaired fasting blood glucose, the administration of
aqueous cinnamon extract also significantly reduced fasting
blood glucose levels [31, 32].
In spite of consistent results regarding fasting blood glu-
cose levels, the effect of cinnamon on postprandial glycaemia
revealed heterogeneous results, which could be attributed
to the bioactive compounds composition (which depends
on extraction process, doses, species, and formulation),
population samples, and study design employed in different
studies [29].
The results of the present study demonstrated that cin-
namon tea administration (6 g of C. burmannii into 100mL
water) slightly reduced PBG level after OGTT.The beneficial
effects of this spice on glycaemia were reported after cinna-
mon powder ingestion where a significant reduction of PBG
after 30min of OGTT was observed [16, 17, 33]. However,
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Figure 1: Mean (±SEM) time course of blood glucose levels
(mmol/L) in nondiabetic subjects after OGTT
(control) (I) and
OGTT
(cinnamon) (◻).
Magistrelli and coauthors [33] showed no effect at 120min
after meal with cinnamon administration, compared with
control meal. Other published data reported that cinnamon
does not alter BGL at 120 minutes after OGTT [16, 17].
Although previous studies demonstrated that 3 g of cin-
namon powder did not significantly alter AUC, 𝐶max and
Δ𝐶max BGL [34], the results from the present work showed
that C. burmannii tea after OGTT significantly reduced 𝐶max
(𝑝 = 0.040) and Δ𝐶max (𝑝 = 0.029) compared with OGTT
without cinnamon tea. This effect may be due to the high
concentration employed in this study (6 g) comparedwith the
other study, which uses 3 g.
Different molecular mechanisms have been suggested
for the hypoglycaemic properties of this spice including
reducing gastric empting [17], insulin-mimetic action [35,
36], which can lead to cellular glucose uptake [23], and
reducing intestinal glycosidase activity.This effect on enzyme
decreased breakdown of disaccharides into glucose, allowing
a slow absorption of glucose and reducing PBG level [37].
The hypoglycaemic effect of cinnamon observed in the
present study could also be attributed to the phenolic content
of C. burmannii tea. According to literature, the molecular
mechanism of action of cinnamon polyphenols includes
the increase of insulin receptor-𝛽 protein in adipocytes
suggesting acting beneficially in insulin signalling [35].
The data from this study suggest that the use of cinnamon
tea can be beneficial to postprandial glucose levels; moreover
its high phenolic content and antioxidant activity could also
act beneficially. A significant relationship was found between
antioxidant properties and total phenolic content in plants,
suggesting that phenols are the bioactive compounds which
contributed to their antioxidants activity [38]. In a study
of Peng and coauthors, they show that proanthocyanidins
of aqueous cinnamon extract can prevent the formation of
advanced glycation-end product (AGE) [39]. AGE could be
originated in high blood glucose levels conditions leading
to reactive oxygen species production [5, 40]. Particularly,
cinnamon tea employed in this study revealed a high activity
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of superoxide anion scavenging, which is in agreement
with other published data demonstrating a strong scavenger
capacity to free radicals in vitromodels [41].
5. Conclusion
Data from this study provide evidence that cinnamon tea
significantly decreased postprandial maximum glucose level
in nondiabetic adults.Themechanism for cinnamon effect on
glycaemia, based on slowing absorption of glucose through
reducing intestinal glycosidase activity, cannot be applied to
the present work since glucose solution was employed. One
possible mechanism proposed to explain the effect of cinna-
mon tea on glycaemia may be related to the insulin action
through the increasing of insulin receptor-𝛽 protein acting
beneficially in insulin signalling. Further studies should be
performed to investigate this mechanism.
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